Cyanobacteria hold significant potential as platforms for the production of a wide variety of high-value products and biofuel molecules such as biohydrogen, isoprenoids and alkanes. Currently, the genome sequences of over 120 cyanobacterial species are publicly available, and techniques for the genetic manipulation of a few species are well established. However, more advanced metabolic engineering technologies are required for high-throughput production/evaluation o